Patient satisfaction and re-audit of the vacuum excision (VACE) pathway for the management of breast lesions of uncertain malignant potential (B3)

Introduction: The VACE pathway was introduced at St Georges Hospital in 2015. The first year’s data was presented at the Association of Breast Surgery (ABS) Conference in 2017. 93 patients were managed by VACE resulting in 17 patients being upgraded to cancer. The complexity of the pathway resulted in three patients breaching the 62 day cancer target. The longest interval in the pathway was between core biopsy and VACE. In response, VACE...